Schulte Roth & Zabel

Schulte Roth & Zabel (SRZ) is a leading, active law firm founded in 1969, headquartered in New York City with additional offices in Washington, D.C., and London. The firm specializes primarily in legal services for the financial sector—especially hedge funds, private equity, investment management firms—and provides counsel on corporate transactions, regulatory compliance, litigation, mergers and acquisitions, intellectual property law (including patents), and more. SRZ is not a life science/biotech/pharma company itself, nor does it develop drugs or medical technologies. While it has represented clients involved in life sciences/biotech/pharma deals as outside counsel (e.g., advising on financings or M&A for healthcare companies), it does not have its own therapeutic pipeline or R&D programs, nor any direct involvement with drug modalities or clinical stages.